1. Home
  2. RVYL vs BMRA Comparison

RVYL vs BMRA Comparison

Compare RVYL & BMRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

RVYL

Ryvyl Inc.

HOLD

Current Price

$7.81

Market Cap

8.5M

ML Signal

HOLD

Logo Biomerica Inc.

BMRA

Biomerica Inc.

HOLD

Current Price

$2.33

Market Cap

7.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RVYL
BMRA
Founded
2007
1971
Country
United States
United States
Employees
N/A
N/A
Industry
Professional Services
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.5M
7.0M
IPO Year
2008
1995

Fundamental Metrics

Financial Performance
Metric
RVYL
BMRA
Price
$7.81
$2.33
Analyst Decision
Hold
Analyst Count
1
0
Target Price
N/A
N/A
AVG Volume (30 Days)
27.2K
17.0K
Earning Date
04-15-2026
04-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$11,131,000.00
$5,311,000.00
Revenue This Year
$770.54
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.14
$1.87
52 Week High
$8.55
$4.60

Technical Indicators

Market Signals
Indicator
RVYL
BMRA
Relative Strength Index (RSI) 67.46 59.04
Support Level $5.00 $2.12
Resistance Level $8.55 $2.40
Average True Range (ATR) 0.65 0.07
MACD 0.11 0.02
Stochastic Oscillator 96.06 61.56

Price Performance

Historical Comparison
RVYL
BMRA

About RVYL Ryvyl Inc.

Ryvyl Inc is a financial technology company that provides payment acceptance and disbursement solutions, mainly enabling merchants to process credit card transactions through BIN sponsorship arrangements with acquiring banks and payment processors, where it operates as an intermediary performing functions such as merchant underwriting, onboarding, risk monitoring, and customer support. The company also offers its internally developed NEMS Core platform, which facilitates automated inbound and outbound disbursements through a modular workflow system.

About BMRA Biomerica Inc.

Biomerica Inc is engaged in the development, manufacturing, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. The Company manages its operations as a single operating and reportable segment, which focus on the development, manufacture, marketing, and sale of diagnostic products. The majority of the company's revenue is earned from the Asia, and also has its presence in Europe, North America, Middle East and South America.

Share on Social Networks: